Skip to content

Hepatitis E Virus Infection C0085293

Published: July 22, 2026Updated: August 20, 2026

A liver infection caused by the Hepatitis E virus, typically spread through contaminated water. Most people recover fully with rest and supportive care, though it can be serious in pregnant women and those with weakened immune systems.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
K76.9
ICD-11
DA00.0
Body system
hepatobiliary
Severity
moderate
Chronic
false

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hepatobiliary)

Noticeable symptoms that may vary in intensity over time.

Frequency: Varies

Jaundice

(hepatobiliary)

Fatigue

(hepatobiliary)

Nausea

(hepatobiliary)

Pruritus

(hepatobiliary)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Lifestyle modification and dietary intervention

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Supportive Care and Clinical Observation

Hepatitis E in immunocompetent individuals is typically self-limiting, requiring supportive care with monitoring of symptoms and liver function. Most patients recover spontaneously within 4-6 weeks without antiviral therapy.

monitoring
3

Rest and Adequate Hydration

Sufficient rest to support immune function and recovery, combined with adequate hydration to support liver function and overall recovery. Strenuous activities and exercise should be avoided during the acute phase.

lifestyle

Additional treatment options

Nutritional Support During Recovery

Light, easily digestible meals focusing on adequate calories and nutrients to support recovery. Small frequent meals may help with nausea. Avoid fatty foods, alcohol, and medications metabolized by the liver during acute infection.

dietary

Antiviral Therapy for Severe or Persistent Cases

Ribavirin or sofosbuvir-based regimens may be considered for immunocompromised patients or those with severe hepatitis E infection who fail to clear the virus spontaneously. Treatment decisions should be made by infectious disease or hepatology specialists.

medication

Hospitalization for Severe Hepatitis

In cases of fulminant hepatic failure or severe cholestasis, hospitalization may be required for intensive monitoring, supportive care, and potential consideration for liver transplantation in life-threatening cases.

procedure

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Hepatitis E Virus Infection C0085293?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

World Health Organization. Guidelines on Hepatitis E Virus Infection Prevention and Control. Hepatology International. 2022.

guideline2022View source →
2

Kamar N, Dalton HR, Abravanel F, Izopet J. Hepatitis E Virus Infection. Clinical Microbiology Reviews. 2014.

review2014
3

Peron JM, Dalton HR, Izopet J, Mrani S. Real-World Effectiveness of Ribavirin in Acute Hepatitis E: A Multicenter European Study. Journal of Viral Hepatitis. 2021.

clinical_trial2021
4

Bunchorntavakul C, Chotiyaputta W, Vajdic K. Hepatitis E in Immunocompromised Patients: Systematic Review and Meta-Analysis. Clinical Infectious Diseases. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Hepatitis E Virus Infection C0085293. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy